The hospital is an effort of the VPS Healthcare group. The new hospital will be the first private facility in the UK to offer Proton Beam Therapy - a type of radiotherapy that uses sub-atomic particles to attack cancer cells with less damage to surrounding tissues than conventional radiotherapy. Proton beam therapy is currently generally unavailable through the NHS (National Health Service), though a small number of UK patients are sent abroad for the treatment if their care team believes they are ideally suited to it.
Dr Shamsheer Vayali, Founder and Managing Director of the VPS Healthcare Group, said that "the new facility will be created within the historic grade II listed Royal Masonic Hospital in Hammersmith which closed in 2006."
The facility will open in 2017 with a bed capacity of 150 and will be supported by around 2,000 staff in jobs ranging from administration, support and service roles to leading specialist healthcare professionals.
The new 'super-specialty' cancer treatment will be available at the hospital through the NHS from 2018.
"VPS Healthcare has been encouraged by the UK Government's ongoing policy to support health and pharmaceutical companies, and we believe that our investment in this dynamic sector will not only ensure that we play a key role in supporting this initiative, but will also help to grow and develop the next generation of medical breakthroughs," said Vayali.
He said that the new London hospital represented a major investment for VPS Healthcare and is its first entry into the UK market. Welcoming the investment, the Mayor of London Boris Johnson said: "This is tremendous vote of confidence in London's thriving life sciences sector as well as the skills and talent of our amazing healthcare professionals."
53,000-Year-Old Hepatitis B Strain in Australia May Help Prevent Liver Cancer
The C4 strain is found only in the northern territory region of Australia which has high rates of liver cancer among Indigenous Australians.
The C4 strain is found only in the northern territory region of Australia which has high rates of liver cancer among Indigenous Australians.
Local Anesthetic Helps Improve the Sex Lives of Breast Cancer Survivors
Application of 4% liquid lidocaine and silicone gel may significantly improve sexual function of breast cancer survivors who experience pain during sexual intercourse.
Application of 4% liquid lidocaine and silicone gel may significantly improve sexual function of breast cancer survivors who experience pain during sexual intercourse.
